Reply to Standaert, B. Comment on “Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium”

Maarten J. Postma; Chih Yuan Cheng; Nasuh C. Buyukkaramikli; Luis Hernandez Pastor; Ine Vandersmissen; Thierry Van Effelterre; Peter Openshaw; Steven Simoens

doi:10.3390/vaccines11111673

Reply to Standaert, B. Comment on “Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium”

Maarten J. Postma, Chih Yuan Cheng, Nasuh C. Buyukkaramikli, Luis Hernandez Pastor, Ine Vandersmissen, Thierry Van Effelterre^*, Peter Openshaw, Steven Simoens

^*Corresponding author voor dit werk

Onderzoeksoutput › Academic › peer review

32 Downloads (Pure)

Originele taal-2	English
Artikelnummer	1673
Aantal pagina's	3
Tijdschrift	Vaccines
Volume	11
Nummer van het tijdschrift	11
DOI's	https://doi.org/10.3390/vaccines11111673
Status	Published - nov.-2023

Toegang tot document

10.3390/vaccines11111673Licentie: CC BY

Reply to Standaert, B.Final publisher's version, 188 KBLicentie: CC BY

Handle.net

Permanente koppeling

Andere bestanden en links

Link naar publicatie in Scopus

Citeer dit

Postma, M. J., Cheng, C. Y., Buyukkaramikli, N. C., Hernandez Pastor, L., Vandersmissen, I., Van Effelterre, T., Openshaw, P., & Simoens, S. (2023). Reply to Standaert, B. Comment on “Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium”. Vaccines, 11(11), Artikel 1673. https://doi.org/10.3390/vaccines11111673

@article{cf96d47bdeb3471c8e91f0a72092d1d4,

title = "Reply to Standaert, B. Comment on “Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium”",

author = "Postma, {Maarten J.} and Cheng, {Chih Yuan} and Buyukkaramikli, {Nasuh C.} and {Hernandez Pastor}, Luis and Ine Vandersmissen and {Van Effelterre}, Thierry and Peter Openshaw and Steven Simoens",

year = "2023",

month = nov,

doi = "10.3390/vaccines11111673",

language = "English",

volume = "11",

journal = "Vaccines",

issn = "2076-393X",

publisher = "MDPI AG",

number = "11",

}

Postma, MJ, Cheng, CY, Buyukkaramikli, NC, Hernandez Pastor, L, Vandersmissen, I, Van Effelterre, T, Openshaw, P & Simoens, S 2023, 'Reply to Standaert, B. Comment on “Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium”', Vaccines, vol. 11, nr. 11, 1673. https://doi.org/10.3390/vaccines11111673

Reply to Standaert, B. Comment on “Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium”. / Postma, Maarten J.; Cheng, Chih Yuan; Buyukkaramikli, Nasuh C. et al.
In: Vaccines, Vol. 11, Nr. 11, 1673, 11.2023.

Onderzoeksoutput › Academic › peer review

TY - JOUR

T1 - Reply to Standaert, B. Comment on “Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium”

AU - Postma, Maarten J.

AU - Cheng, Chih Yuan

AU - Buyukkaramikli, Nasuh C.

AU - Hernandez Pastor, Luis

AU - Vandersmissen, Ine

AU - Van Effelterre, Thierry

AU - Openshaw, Peter

AU - Simoens, Steven

PY - 2023/11

Y1 - 2023/11

UR - http://www.scopus.com/inward/record.url?scp=85178123145&partnerID=8YFLogxK

U2 - 10.3390/vaccines11111673

DO - 10.3390/vaccines11111673

M3 - Comment/Letter to the editor

AN - SCOPUS:85178123145

SN - 2076-393X

VL - 11

JO - Vaccines

JF - Vaccines

IS - 11

M1 - 1673

ER -

Postma MJ, Cheng CY, Buyukkaramikli NC, Hernandez Pastor L, Vandersmissen I, Van Effelterre T et al. Reply to Standaert, B. Comment on “Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium”. Vaccines. 2023 nov.;11(11):1673. doi: 10.3390/vaccines11111673